We have shown previously that exposing human CF monocyte-derived macrophages to lumacaftor and ivacaftor reduced transferrin receptor 1 expression, corrects dysfunctional iron transport gene expression observed in CF (57), and that lumacaftor restores the ability of CF macrophages to phagocytose and kill Pseudomonas (58). Here, TFRC is linked to cystic fibrosis.